Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Cancer Centers Support Grants

Number: 93.397
Agency: Department of Health and Human Services
Office: National Institutes of Health

Program Information 

Program Number/Title (010):
93.397 Cancer Centers Support Grants
Federal Agency (030):
National Institutes of Health, Department of Health and Human Services
Authorization (040):
Public Health Service Act, Section 305(a), 410, 411, and 414, Public Law 78-410, 42 U.S.C. 241, as amended; Public Law 100-607, 42 U.S.C. 285, 285a and 285a-3; Public Law 99-500.
Objectives (050):
To provide an organizational focus and stimulus for the highest quality cancer research that effectively promotes interdisciplinary cancer research aimed toward the ultimate goal of reducing cancer incidence, mortality and morbidity. The Cancer Center Support Grant (CCSG) provides the resources and infrastructure to facilitate the coordination of interdisciplinary programs across a broad spectrum of research from basic laboratory research to clinical investigation to population science. The CCSG supports salaries for scientific leadership of the Center, shared resources for funded center investigators, certain administrative costs, planning and evaluation, and developmental funds for new recruitments and feasibility studies.
Types of Assistance (060):
Cooperative Agreements; Project Grants
Uses and Use Restrictions (070):
In general, CCSGs do not support research projects directly but are used to enhance the ongoing cancer research and to strengthen the existing research base according to the "Policies and Guidelines Relating to the Cancer Center Support Grant.".
Eligibility Requirements (080)
Applicant Eligibility (081):
Any nonprofit institution within the United States with a peer-reviewed cancer research base of 4.0 million dollars in direct costs may apply for a Cancer Center Support Grant.
Beneficiary Eligibility (082):
University, college, public agency or research institution in the U.S.
Credentials/Documentation (083):
The application requests documentation concerning the qualifications of the principal investigators and associates, pertinent budget information and justification for the support of this proposed grant. Methods to be utilized are outlined in the application materials. Costs will be determined in accordance with HHS Regulations 45 CFR, Part 74, Subpart Q, and for State and local governments in accordance with OMB Circular No. A-87. OMB Circular No. A-87 applies to this program.
Application and Award Process (090)
Preapplication Coordination (091):
Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.
Application Procedures (092):
This program is excluded from coverage under OMB Circular No. A-102. OMB Circular No. A-110 applies to this program. Method of Application: Form PHS-398 (Rev. June 2009) can be obtained from the website (click on PHS-398). In addition, supplemental instructions for applications are contained in the Cancer Center Support Grant Guidelines which can be obtained by writing to the Office of Cancer Centers, 6116 Executive Boulevard, Suite 700, MSC 8345, Bethesda, MD 20892-8345 (301-496-8531 or Generally, the potential applicant should send a letter of intent to the National Cancer Institute, Office of Cancer Centers, submitting a CCSG application to the same address for review (see Guidelines for CCSGs). Completed applications should be submitted to the Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. This program is subject to the provisions of 45 CFR, Part 92 for State and local governments and OMB Circular No. A-110 for nonprofit organizations.
Award Procedure (093):
Grants are funded based on scientific merit, program relevance, and program balance and are made annually. Initial award provides funds for the first budget period (usually 12 months) and Notice of Grant Award (Form PHS 1533) indicates support recommended for the remainder of the project period, allocation of Federal funds by budget categories and special conditions, if any.
Deadlines (094):
Contact the headquarters or regional office, as appropriate, for application deadlines.
Range of Approval/Disapproval Time (095):
Core Grants: Approximately 10 months.
Appeals (096):
A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on and NIH Policy Manual Release date: February 7, 2012
Renewals (097):
Same procedure as new applications.
Assistance Consideration (100)
Formula and Matching Requirements (101):
This program has no statutory formula.
Matching requirements are not applicable to this program.
MOE requirements are not applicable to this program.
Length and Time Phasing of Assistance (102):
Up to 5 years of support may be requested. Grants may be awarded up to 5 years based on competitive peer review. Method of awarding/releasing assistance: by letter of credit.
Post Assistance Requirements (110)
Reports (111):
No program reports are required. No cash reports are required. Progress reports are required each year. An annual financial status report is requested 90 days after the end of the budget period. Special reports may be requested by DHHS. Terminal reports are required 90 days after the end of a project. No expenditure reports are required. No performance monitoring is required.
Audits (112):
In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal officials.
Records (113):
Expenditures and other financial records must be retained for 3 years from the day on which the grantee submits the last financial status report for the report period.
Financial Information (120)
Obligations (122):
(Project Grants) FY 13 $530,339,000; FY 14 est $547,007,000; and FY 15 est $563,363,000 - Cancer Centers Support Grants.
Range and Average of Financial Assistance (123):
Range: $1,000 to $12,328,405
Average: $2,055,578.
Program Accomplishments (130):
Fiscal Year 2013: FY 2013 Centers funded: 258 Centers, 68 CORES, 54 SPORE and 111 Specialized Centers. Fiscal Year 2014: Fiscal year 2014 will fund an estimated 259 total Centers which will include 68 COREs, 54 SPOREs and 111 Specialized Centers. Fiscal Year 2015: Fiscal year 2015 will fund an estimated 259 total Centers which will include 68 COREs, 54 SPOREs and 111 Specialized Centers.
Regulations, Guidelines, and Literature (140):
42 CFR 52; 45 CFR 74; 45 CFR 92; PHS Grants Policy Statement, DHHS Publication No. (OASH) 90- 50,000, (Rev.) October 1, 1990.
Information Contacts (150)
Regional or Local Office (151) :
None. None.
Headquarters Office (152):
Catherine M. Battistone, 9609 Medical Center Drive
Seventh Floor, West Tower, 7W532, MSC 9750, Rockville, Maryland 20850 Email: Phone: 240-276-6443 Fax: 240-276-7682
Website Address (153):
Examples of Funded Projects (170):
Not Applicable.
Criteria for Selecting Proposals (180):
The major elements in evaluating applications include the following: (1) An adequate base of established programs of high quality in laboratory and clinical cancer research; (2) research activity in a variety of disciplines, and evidence of high degree of interdisciplinary coordination, interaction and cooperation among center members; (3) appropriate and adequate organization and facilities for the conduct and evaluation of center activities; (4) a qualified director with adequate authority; and (5) an adequate commitment of the parent institution or institutions to the cancer center. The center should be recognized as a major element within the organizational structure.